Zy Therapeutics at AES 2025: Advancing Treatments for Rare Epilepsies

  • Published
  • 1 min read

– December 5-9, 2025 | Atlanta –

Zy Therapeutics will be attending AES 2025 in Atlanta, Georgia, where the team will highlight ongoing work toward developing a disease-modifying treatment for Sturge-Weber Syndrome, Tuberous Sclerosis Complex, and Neurocysticercosis.

As always, we look forward to connecting with colleagues, collaborators, and potential partners who share our commitment to advancing care for rare epilepsies.